Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins

Melanoma and Skin Cancer

Risk Factors of Subsequent Primary Melanomas in Austria

JAMA Dermatol.

Müller C, Wendt J, Rauscher S, Sunder-Plassmann R, Richtig E, Fae I, Fischer G, Okamoto I

Melanoma and Skin Cancer

Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis

JAMA Dermatol.

Nelson KC, Swetter SM, Saboda K, Chen SC, Curiel-Lewandrowski C

doi: 10.1001/jamadermatol.2019.1514.

Melanoma and Skin Cancer

Intra-nodal nevi in sentinel node negative patients with cutaneous melanoma does not influence survival

J Eur Acad Dermatol Venereol.

de Beer FSA, van Diest PJ, Sigurdsson V, El Sharouni M

doi: 10.1111/jdv.15814.

Melanoma and Skin Cancer

Non-Invasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma

J Invest Dermatol.

Ferris L, Moy R, Gerami P, Sligh JE, Jansen B, Yao Z, Cockerell CJ

doi: 10.1016/j.jid.2018.10.041.

Melanoma and Skin Cancer

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

Lancet.

Utjés D, Malmstedt J, Teras J, Drzewiecki K, Gullestad HP, Ingvar C, Eriksson H, Gillgren P

doi: 10.1016/S0140-6736(19)31132-8.

Melanoma and Skin Cancer

Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor

JAMA Dermatol.

von Schuckmann LA, Hughes MCB, Ghiasvand R, Malt M, van der Pols JC, Beesley VL, Khosrotehrani K, Smithers BM, Green AC

doi: 10.1001/jamadermatol.

Melanoma and Skin Cancer

Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual

JAMA Dermatol.

Isom C, Wheless L, Hooks MA, Kauffmann RM

doi: 10.1001/jamadermatol.

Melanoma and Skin Cancer

Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma

JAMA Dermatol

El Sharouni MA, Aivazian K, Witkamp AJ, Sigurdsson V, van Gils CH, Scolyer RA, Thompson JF, van Diest PJ, Lo SN

doi: 10.1001/jamadermatol.2020.5032

Melanoma and Skin Cancer

Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients

J Am Acad Dermatol.

Greenhaw BN, Covington KR, Kurley SJ, Yeniay Y, Cao NA, Plasseraud KM, Cook RW, Hsueh EC, Gastman BR, Wei ML

doi: 10.1016/j.jaad.2020.03.053.

Related content

Risk Factors of Subsequent Primary Melanomas in Austria

Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis

Intra-nodal nevi in sentinel node negative patients with cutaneous melanoma does not influence survival

Non-Invasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor

Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual

Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma

Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients